Method of forming bioabsorbable drug delivery devices
View Patent ↗A bioabsorbable drug delivery device and various methods of making the same. The devices are preferably formed from bioabsorbable materials using low temperature fabrication processes, hereby drugs or other bio-active agents are incorporated into or onto the device and degradation of the drugs or other agents during processing is minimized. Radiopaque markers may also be incorporated into, or onto, the devices. The devices may be generally tubular helical stents comprised of a solid ladder or an open lattice configuration, or a hybrid combination thereof. The tubular helical stents are generally formed from precursor fibers, films or tubes. The solid ladder configuration provides increased radiopacity and increased radial strength, whereas the open lattice configuration provides better endothelialization and fluid flow through the stent. The drug or other agent delivery capacity of the devices may provide local or regionalized drug or other agent delivery, or a combination thereof, with more consistent concentrations of drugs or other agents delivered from the device to the treatment site along the entire length of the device.
1. A method of forming a drug delivery device, the method comprising:
adding at least one polymer resin to a solvent until the polymer dissolves completely in the solvent to form a first polymer solution;
adding at least one polymer resin to a solvent until the polymer dissolves completely in the solvent to form a second polymer solution;
co-extruding a first bioabsorbable polymer tube having a first melting point from the first solution and a second bioabsorbable polymer tube having a second melting point from the second solution at the same time to form a coaxial sheath and core, respectively, of a stent having luminal and abluminal surfaces, wherein the first melting point is lower than the second melting point.
2. The method of claim 1 , wherein the sheath comprises at least one of polycaprolactone and polydioxanone.
3. The method of claim 1 , further comprising coating the drugs or bioactive agents onto the device after extrusion thereof.
4. The method of claim 1 , further comprising incorporating radiopaque materials into, or onto, the device.
5. The method of claim 1 wherein the first bioabsorbable polymer tube comprises a material having a low melting point.
6. The method of claim 5 wherein the melting point is between approximately 60° C. to about 100° C.
7. The method of claim 1 wherein the first bioabsorbable polymer tube comprises at least one drug or other bioactive agent.
8. The method of claim 7 wherein the at least one drug or other bioactive agent is incorporated into the polymer matrix by adding the at least one drug or other bioactive agent and the first bioabsorbable polymer together in a solution until the at least one drug or other bioactive agent and the first bioabsorbable polymer dissolve completely in the solvent to form a homogenous solution.
9. The method of claim 1 wherein the second bioabsorbable polymer tube comprises at least one drug or other bioactive agent.
10. The method of claim 9 wherein the at least one drug or other bioactive agent is incorporated into the polymer matrix by adding the at least one drug or other bioactive gent and the second bioabsorbable polymer together in a solution until the at least one drug or other bioactive agent and the second bioabsorbable polymer dissolve completely in the solvent to form a homogenous solution.
11. The method of claim 4 wherein the radiopaque material is incorporated into the polymer matrix of the first bioabsorbable polymer tube.
12. The method of claim 4 wherein the radiopaque material is coated over at least a portion of the first bioabsorbable polymer tube.
13. The method of claim 1 wherein the bioabsorbable polymer tube comprising a material having a high melting point to provide strength.